Breaking News Instant updates and real-time market news.

GI

EndoChoice

, BSX

Boston Scientific

$20.76

-0.395 (-1.87%)

15:47
11/28/16
11/28
15:47
11/28/16
15:47

Gabelli liquidates stake in EndoChoice

As a result of the completion of the acquisition of the company by Boston Scientific (BSX), Gabelli no longer has beneficial ownership of any of the company's shares. On October 20, Gabelli reported a 5.08% stake in EndoChoice.

GI

EndoChoice

BSX

Boston Scientific

$20.76

-0.395 (-1.87%)

  • 29

    Nov

  • 06

    Dec

  • 07

    Dec

  • 07

    Dec

  • 12

    Dec

GI EndoChoice

03/24/16
03/24/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Petrobras (PBR) downgraded to Sell at Deutsche Bank by analyst Alexander Burgansky, who said he sees no upside for the equity with negative net income likely in both 2016 and 2017. 2. Lannett (LCI) downgraded to Sell at Canaccord after the company cut its guidance to below consensus expectations. 3. Cognex (CGNX) downgraded to Underperform at CLSA by analyst Jeremie Capron, who said Apple's (AAPL) new iPhone SE is essentially a refreshed iPhone 5S, which will likely be made with older equipment and raises the risk that Cognex will not meet lofty consensus expectations. Capron sees increased earnings risk for the rest of the year given the weaker manufacturing capex environment and developments at Apple and views risk/reward as unfavorable following the recent strength. 4. EndoChoice (GI) downgraded to Underperform at BofA/Merrill due to expectations that low margin microcaps will not outperform enough to compensate for the relative risk taken. 5. General Dynamics (GD) downgraded to Hold at Deutsche Bank by analyst Myles Walton, who said Gulfstream G650 inventory and price trends are "quickly becoming a problem." Walton added that the available for sale G650s moved from 9 to 22 over the last five months. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/13/16
JPMS
07/13/16
INITIATION
Target $10
JPMS
Overweight
EndoChoice assumed with an Overweight at JPMorgan
JPMorgan analyst Robbie Marcus assumed coverage of EndoChoice with an Overweight rating and $10 price target. The rating and price target are unchanged.
08/04/16
JPMS
08/04/16
DOWNGRADE
Target $5.5
JPMS
Neutral
EndoChoice downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Robbie Marcus downgraded EndoChoice to Neutral citing concerns over profitability and a lack of conviction in the Fuse adoption rate following the company's "disappointing" Q2 results. The analyst cut his price target for the shares to $5.50 from $10.
08/04/16
WBLR
08/04/16
DOWNGRADE
WBLR
Market Perform
EndoChoice downgraded to Market Perform from Outperform at William Blair
William Blair analyst Margaret Kaczor downgraded EndoChoice to Market Perform after lowering her estimates following the company's weaker than expected Q2 results. JPMorgan this morning also downgraded EndoChoice.
BSX Boston Scientific
$20.76

-0.395 (-1.87%)

06/08/16
GUGG
06/08/16
INITIATION
Target $26
GUGG
Buy
Boston Scientific initiated with a Buy at Guggenheim
Guggenheim analyst Chris Pasquale initiated Boston Scientific with a Buy rating and price target of $26.
08/01/16
STFL
08/01/16
NO CHANGE
STFL
Boston Scientific estimates raised at Stifel
Stifel analyst Rick Wise raised his estimates for Boston Scientific citing clinicians' increased optimism about the company's Lotus transcatheter aortic valve replacement product. Wise now expects Lotus to have a 20% share of the market in 2020, up from 12% previously. He keeps a $28 price target and Buy rating on the stock.
09/01/16
ARGS
09/01/16
UPGRADE
ARGS
Buy
Boston Scientific upgraded to Buy from Hold at Argus
Argus analyst David Toung believes that Boston Scientific reported "strong" Q2 sales, while the company is gaining share. He thinks that the stock's valuation is attractive. Target $33.
09/01/16
09/01/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Boston Scientific (BSX) upgraded to Buy from Hold at Argus by analyst David Toung, who believes that the company reported "strong" Q2 sales and is gaining share. 2. WEX Inc. (WEX) upgraded to Outperform from Underperform at CLSA by analyst Tom McCrohan who increased his average fuel price outlook, which resulted in an increase in earnings contribution of approximately 30c per share for both 2017 and 2018. Additionally, the analyst said management is beginning to implement higher late fees on its small business clients, which can unlock 90c per share of additional earnings power as small fleet customers incur higher late fees on overdue balances. 3. Nomura (NMR) upgraded to Hold from Underperform at Jefferies by analyst Makarim Salman, who still cautions investors not to "chase the momentum" following the company's positive Q1 earnings. 4. Seacoast Banking (SBCF) upgraded to Outperform from Market Perform at Keefe Bruyette by analyst Jefferson Harralson, who thinks the company is about to "ramp to a meaningfully higher profitability" following its efficiency improvements. 5. Randgold (GOLD) upgraded to Buy from Hold at Canaccord, citing valuation following its Q2 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

FIBK

First Interstate

$42.80

0.2 (0.47%)

15:01
01/23/18
01/23
15:01
01/23/18
15:01
Hot Stocks
First Interstate names Renee Newman chief banking officer »

First Interstate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSC

Norfolk Southern

$150.73

-0.74 (-0.49%)

14:57
01/23/18
01/23
14:57
01/23/18
14:57
Hot Stocks
Norfolk Southern increases quarterly dividend 18% to 72c per share »

Norfolk Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

FBM

Foundation Building Materials

$15.36

-0.14 (-0.90%)

14:52
01/23/18
01/23
14:52
01/23/18
14:52
Conference/Events
Foundation Building Materials has a conference call hosted by Willian Blair »

William Blair will host a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

MAT

Mattel

$16.09

-0.05 (-0.31%)

14:50
01/23/18
01/23
14:50
01/23/18
14:50
Options
Timely call buying in Mattel »

Timely call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 20

    Feb

HMNY

Helios and Matheson

$8.27

0.19 (2.35%)

14:45
01/23/18
01/23
14:45
01/23/18
14:45
Options
Helios and Matheson call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAT

Mattel

$16.09

-0.05 (-0.31%)

, HAS

Hasbro

$90.86

-1.7 (-1.84%)

14:42
01/23/18
01/23
14:42
01/23/18
14:42
Periodicals
Mattel gives CNN no comment on stock jump »

Paul La Monica of CNN…

MAT

Mattel

$16.09

-0.05 (-0.31%)

HAS

Hasbro

$90.86

-1.7 (-1.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 20

    Feb

  • 20

    Feb

AAPL

Apple

$177.00

-1.46 (-0.82%)

14:41
01/23/18
01/23
14:41
01/23/18
14:41
Recommendations
Apple analyst commentary  »

JPMorgan sees more signs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

GE

General Electric

$16.96

0.785 (4.85%)

14:30
01/23/18
01/23
14:30
01/23/18
14:30
Options
Heavy trading in GE as shares rally ahead of earnings »

Heavy trading in GE as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

SNE

Sony

$51.00

0.2 (0.39%)

, AAPL

Apple

$177.00

-1.46 (-0.82%)

14:25
01/23/18
01/23
14:25
01/23/18
14:25
Downgrade
Sony, Apple rating change  »

Sony downgraded to…

SNE

Sony

$51.00

0.2 (0.39%)

AAPL

Apple

$177.00

-1.46 (-0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 01

    Feb

EXAS

Exact Sciences

$48.49

0.67 (1.40%)

14:25
01/23/18
01/23
14:25
01/23/18
14:25
Options
EXACT Sciences call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

MAT

Mattel

$16.09

-0.05 (-0.31%)

, HAS

Hasbro

$90.86

-1.7 (-1.84%)

14:22
01/23/18
01/23
14:22
01/23/18
14:22
Hot Stocks
Breaking Hot Stocks news story on Mattel, Hasbro »

Mattel, Hasbro rally to…

MAT

Mattel

$16.09

-0.05 (-0.31%)

HAS

Hasbro

$90.86

-1.7 (-1.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 20

    Feb

  • 20

    Feb

FB

Facebook

$185.37

4.08 (2.25%)

14:18
01/23/18
01/23
14:18
01/23/18
14:18
Hot Stocks
Facebook CMO leaving to advise other companies, help Democratic Party »

In a status update, Gary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 28

    Feb

$NSD

NASDAQ Market Internals

14:17
01/23/18
01/23
14:17
01/23/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
01/23/18
01/23
14:16
01/23/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$89.35

-1.29 (-1.42%)

14:15
01/23/18
01/23
14:15
01/23/18
14:15
Options
Wayfair put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

TWTR

Twitter

$22.84

-0.5 (-2.14%)

14:13
01/23/18
01/23
14:13
01/23/18
14:13
Recommendations
Twitter analyst commentary  »

Noto departure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

AAPL

Apple

$177.00

-1.46 (-0.82%)

14:10
01/23/18
01/23
14:10
01/23/18
14:10
Periodicals
KGI's Kuo says Apple's next iPhone to have no 3D touch, MacRumors reports »

Apple may launch a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

SNE

Sony

$51.80

0.995 (1.96%)

14:10
01/23/18
01/23
14:10
01/23/18
14:10
Downgrade
Sony rating change  »

Sony downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

14:10
01/23/18
01/23
14:10
01/23/18
14:10
General news
U.S. equities cooled off from record highs »

U.S. equities cooled off…

BTC

Bitcoin

, BITCOIN

Bitcoin

14:09
01/23/18
01/23
14:09
01/23/18
14:09
Hot Stocks
Stripe says ending Bitcoin support »

Tom Karlo, Stripe's…

BTC

Bitcoin

BITCOIN

Bitcoin

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REG

Regency Centers

$64.46

0.15 (0.23%)

14:08
01/23/18
01/23
14:08
01/23/18
14:08
Hot Stocks
Regency Centers acquires Whole Foods Market-anchored center in New Jersey »

Regency Centers …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Feb

TEVA

Teva

$20.80

-0.22 (-1.05%)

, JNJ

Johnson & Johnson

$142.63

-5.51 (-3.72%)

14:06
01/23/18
01/23
14:06
01/23/18
14:06
Hot Stocks
NYC sues drug manufacturers, distributors over opioid epidemic »

New York City Mayor Bill…

TEVA

Teva

$20.80

-0.22 (-1.05%)

JNJ

Johnson & Johnson

$142.63

-5.51 (-3.72%)

ENDP

Endo

$7.31

0.2 (2.81%)

MCK

McKesson

$171.56

-1.405 (-0.81%)

CAH

Cardinal Health

$73.46

-0.05 (-0.07%)

ABC

AmerisourceBergen

$102.96

0.3 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 01

    Feb

  • 06

    Feb

  • 08

    Feb

  • 16

    Feb

  • 08

    Mar

SHLD

Sears

$3.45

-0.18 (-4.96%)

14:05
01/23/18
01/23
14:05
01/23/18
14:05
Hot Stocks
Fitch downgrades Sears Holdings to 'C' on distressed debt exchange announcement »

Fitch Ratings has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOLD

Amicus

$15.97

0.07 (0.44%)

14:05
01/23/18
01/23
14:05
01/23/18
14:05
Options
Amicus call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSC

Norfolk Southern

$150.81

-0.66 (-0.44%)

14:03
01/23/18
01/23
14:03
01/23/18
14:03
Hot Stocks
Breaking Hot Stocks news story on Norfolk Southern »

Norfolk Southern trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.